2. What you need to know before you take 2.5 mg film-coated tablets
The diagnosis of a migraine episode must have been clearly established by your doctor.
Do not take <Invented name> 2.5 mg film-coated tablets:
- If you are allergic to frovatriptan, or any of the other ingredients of this medicine (listed in section 6)
- If you have a heart problem such as heart failure or chest pains (angina), or have already had a heart attack
- If you have circulation problems in your legs that cause cramp-like pains when you walk (peripheral vascular disease)
- If you have had a stroke or a mini-stroke (also called a transient ischaemic attack or TIA)
- If you have moderate to severe high blood pressure. You may be able to take <Invented name> 2.5 mg film-coated tablets if your high blood pressure is mild and is being treated
- If you have severe liver disease
- With other migraine medicines, including those which contain ergotamine, or with similar medicines such as methysergide, or with other 5-HT1 receptor agonists, such as sumatriptan.
If any of these apply to you, tell your doctor, and do not take <Invented name> 2.5 mg film-coated tablets.
ID: PL169M – NL/H/2757/01/DC, NL/H/2758/01/DC, |
Version: 01 |
Effective Date: 03/07/13 |
NL/H/2759/01/DC & NL/H/2762/01/DC | | |
Warnings and precautions
Talk to your doctor or pharmacist before taking<Invented name> 2.5 mg film-coated tablets
Take special care with <Invented name> 2.5 mg film-coated tablets if you are a patient with cardiovascular risk factors, including if:
- You are a heavy smoker or taking smoking-cessation medicines
- If you are a woman in post-menopause or a man over 40 years of age.
In these cases, ask your doctor for advice before taking <Invented name> 2.5 mg film-coated tablets.
In some rare cases, symptoms such as chest pain and feeling of heaviness may appear in patients on triptans, even in cases with no history of cardiovascular diseases.
If you notice any of these symptoms, contact your doctor and do not take any further doses of this medicine.
Other medicines and <Invented name> 2.5 mg film-coated tablets
Tell your doctor if you are taking, have recently taken or might take any other medicines.
Do not take this medicine at the same time as certain other medicines used to treat migraines:
- Especially ergotamine and ergotamine derivatives (including methysergide), sumatriptan or other 5-HT1 receptor agonists; a period of at least 24 hours must be observed between stopping these medicines and administering <Invented name> 2.5 mg film-coated tablets. Similarly, these medicines must not be administered within 24 hours of administering frovatriptan.
- Particularly other triptans (5-HT1 agonists, such as sumatriptan, almotriptan, eletriptan, naratriptan, rizatriptan or zolmitriptan).
Do not take this medicine, unless otherwise advised by your doctor, at the same time as monoamine oxidase inhibitors (MAOI) type medicines used to treat depression (iproniazid, isocarboxazid, tranylcypromine, moclobemide).
Inform your doctor or pharmacist if you are taking oral contraceptives (the pill) or selective serotonin re-uptake inhibitors (citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline).
Taking < Invented name > 2.5 mg film-coated tablets together with St John's Wort (Hypericum perforatum) is not recommended.
The combination of <Invented name> 2.5 mg film-coated tablets with the above medicines (particularly monoamine oxidase inhibitors, selective serotonin reuptake inhibitors and St John's Wort) may increase the risk of serotonin syndrome (the symptoms of this syndrome include: chills, sweating, agitation, muscle tremor and spasm, nausea, fever and confusion).
If you have any doubts about the use of other medicines and <Invented name> 2.5 mg film-coated tablets, ask your doctor or pharmacist.
< Invented name > 2.5 mg film-coated tablets with food and drink
<Invented name> 2.5 mg film-coated tablets may be taken with food or fasting, and always with plenty of water.
Pregnancy and breast-feeding
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Unless otherwise advised by your doctor, the use of <Invented name> 2.5 mg film-coated tablets is not recommended while pregnant or breast-feeding.
In any case, you should not breast-feed for 24 hours after taking the medicine. The milk expressed during this period should be discarded.
ID: PL169M – NL/H/2757/01/DC, NL/H/2758/01/DC, |
Version: 01 |
Effective Date: 03/07/13 |
NL/H/2759/01/DC & NL/H/2762/01/DC | | |
Driving and using machines
- Either the symptoms of migraine or your medicine may make you drowsy. If you are affected, do not drive or use any tools or machines.
<Invented name> 2.5 mg film-coated tablets contains lactose
<Invented name> 2.5 mg film-coated tablets contain a small amount of a sugar called lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking <Invented name> 2.5 mg film-coated tablets.